Management After Hartmann's Procedure for Acute Sigmoid Diverticulitis
The primary future management goal is to evaluate for Hartmann's reversal (colostomy takedown with restoration of bowel continuity) at least 3 months after the initial surgery, with the decision based on patient fitness, absence of ongoing sepsis, and confirmation that remaining colon is healthy.
Immediate Post-Operative Period (First 3 Months)
Recovery and Healing
- Allow adequate time for inflammatory adhesions to resolve and surgical margins to heal before considering reversal 1
- Monitor for complications including wound infections, intra-abdominal abscesses, and stoma dysfunction
- The 3-month minimum interval is critical—attempting earlier reversal increases technical difficulty and complication risk 1, 2
Stoma Management
- Educate patient on proper stoma care
- Be aware that 7-32% of patients may develop stoma dysfunction requiring intervention 3
- Counsel patients that without reversal, 9-43% may end up with permanent colostomy 3
Planning for Hartmann's Reversal (After 3+ Months)
Pre-Reversal Evaluation
Perform contrast enema or colonoscopy to assess:
- Extent of remaining healthy sigmoid colon 4
- Presence of residual diverticular disease
- Adequacy of distal rectal stump
- Rule out colorectal malignancy if not previously done 5
Critical timing note: Colonoscopy should be performed 6-8 weeks after resolution of acute inflammation to exclude misdiagnosis of colonic neoplasm (detects 15 colorectal cancers and 38 advanced adenomas per 1000 patients) 5
Decision Algorithm for Reversal
Proceed with reversal if:
- Patient is medically fit for surgery
- No ongoing sepsis or inflammation
- Adequate length of healthy colon remains
- Patient desires restoration of continuity
- No contraindications (severe comorbidities, immunosuppression)
Consider permanent colostomy if:
- Patient age >70 years with multiple comorbidities 6
- Extensive residual diverticular disease requiring further resection
- Patient preference to avoid additional surgery
- Poor functional status or life expectancy
Reversal Technique Considerations
- Primary anastomosis is preferred over repeat Hartmann's when feasible 3, 7
- Primary anastomosis with covering stoma has lower morbidity than Hartmann's reversal alone 3
- Anastomotic leak rate after Hartmann's reversal is approximately 15.7% 7
- Expect 3 anastomotic leaks per 21 reversals in the Hartmann group versus 0 per 27 in primary anastomosis groups 3
Long-Term Management After Reversal or With Permanent Colostomy
Lifestyle Modifications to Prevent Recurrence
Strongly recommend:
- High-fiber diet or fiber supplementation (conditional recommendation, though evidence is extrapolated) 5
- Vigorous physical activity 5
- Avoid non-aspirin NSAIDs if possible (increases diverticulitis risk) 5
Do NOT restrict:
Medications to AVOID
- Do NOT use mesalamine for prevention (strong recommendation against) 5
- Do NOT use rifaximin for prevention 5
- Do NOT use probiotics for prevention 5
Special Considerations
Immunosuppressed Patients
If patient is chronically immunosuppressed, consultation with colorectal surgeon is mandatory even after successful Hartmann's procedure, as this population has high risk for complicated recurrence 8
Risk of Recurrent Diverticulitis
- Even after sigmoid resection, 15% will have recurrent diverticulitis at 5 years (versus 61% with non-operative management) 8
- Surgery reduces but does not eliminate risk
- 22-25% continue to have ongoing abdominal pain after surgery 8
Mortality Considerations
The 30-day mortality after Hartmann's procedure for perforated diverticulitis is approximately 20.8%, with higher rates (38.1%) in Hinchey Grade IV disease 6. Admission hypotension (SBP <90 mmHg) is the strongest independent predictor of mortality 6.
Common Pitfalls to Avoid
- Attempting reversal too early (<3 months)—increases technical difficulty and complications
- Failing to obtain pre-reversal imaging—may miss residual disease or malignancy
- Not counseling about permanent colostomy risk—9-43% may never achieve reversal
- Prescribing mesalamine, rifaximin, or probiotics—no benefit and wastes resources
- Restricting dietary seeds/nuts—unnecessary and reduces quality of life